uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
What Is the Most Cost-Effective Strategy for Treating Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia (CML) after Imatinib Loses Patent Exclusivity?
Show others and affiliations
2014 (English)In: Blood, ISSN 0006-4971, E-ISSN 1528-0020, Vol. 124, no 21Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2014. Vol. 124, no 21
National Category
URN: urn:nbn:se:uu:diva-249072ISI: 000349242707105OAI: oai:DiVA.org:uu-249072DiVA: diva2:806068
Available from: 2015-04-17 Created: 2015-04-10 Last updated: 2015-04-17Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Simonsson, Bengt
By organisation
In the same journal

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 178 hits
ReferencesLink to record
Permanent link

Direct link